Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/638
Title: Kinetics of 5-fluorouracil degradation by heterogenous TiO2 photocatalysis
Authors: Constantin, Lucian Alexandru
Nitoi, Ines
Cristea, Ionut
Oancea, Petruta
Keywords: 5-Fluorouracil;Photocatalysis;TiO2 photocatalyst
Issue Date: 2016
Publisher: SYSCOM 18 SRL
Abstract: 
Cytostatic drugs represents a category of pharmaceutical products used in cancer treatment, and among
them 5-fluorouracil is the most common. Drugs used in cancer treatment are inhibiting and even destroying
the cells, acting in a non-selective manner and therefore being considered to present carcinogenic, genotoxic, mutagenic and teratogenic potential. About 15% of the administered 5-fluorouracil is eliminated from human body without any transformation and therefore ends up in the wastewater system. Due to the fact that removal of 5-fluoruracil and other pharmaceutical products using conventional wastewater treatment is incomplete and inefficient, there is a need for more performant degradation technologies such as advanced oxidation processes. Among them, photocatalytic oxidation using titanium dioxide represents one of the most efficient removal technology for hazardous organic compounds. UV/TiO2 degradation of 5-fluorouracil was investigated in the aim to optimize process operational parameters: pH = 7, photocatalyst dose = 100 mg/L, irradiation time = 180 min. The degradation kinetic of 5-fluorouracil was found to follow Langmuir – Hinshelwood model and degradation rate constant kr=3.74 x 10-6 M min-1 and equilibrium constant of 5- fluorouracil adsorption on photocatalyst particles Kad = 9505 M-1 were determined.
Description: 
Revista de Chimie (Bucuresti) Volume 67 Issue 8
URI: http://hdl.handle.net/123456789/638
ISSN: 2537-5733
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat
Kinetics of 5fluorouracil.pdf943.02 kBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.